Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Gastric or Gastroesophageal Junction Adenocarcinoma
Los Angeles, California
Gastric or Gastroesophageal Junction Adenocarcinoma Clinical Trials in Los Angeles, California
1 recruiting
Los Angeles, California
Showing
1–1
of
1
trials
Recruiting
Phase 1
Phase 2
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
Pancreatic Ductal Adenocarcinoma
Biliary Tract Cancer (BTC)
Gastric or Gastroesophageal Junction Adenocarcinoma
Phanes Therapeutics
258 enrolled
11 locations
NCT05482893
Feedback